Subscribe free to our newsletters via your
. 24/7 Space News .




CLONE AGE
Banning federal funding for human embryonic stem cell research would derail related work
by Staff Writers
Ann Arbor MI (SPX) Jun 15, 2011


Owen-Smith and his colleagues examined stem cell research papers published between 1998 and 2010. They found that the proportion of papers using iPS cells and human embryonic stem cells together is growing faster than those using iPS cells alone.

Banning federal funding for human embryonic stem cell research would have "disastrous consequences" on the study of a promising and increasingly popular new stem cell type that is not derived from human embryos, according to a University of Michigan researcher and his colleagues.

Human induced pluripotent stem cells, known as iPS cells, are reprogrammed adult cells that display many of the most scientifically valuable properties of embryonic stem cells while enabling researchers to bypass embryos altogether. Scientists hope to harness the power of both cell types to understand and treat disease, and possibly to grow new tissues to replace diseased organs.

When they burst onto the scene in 2007, iPS cells were heralded by some as likely replacements for the controversial human embryonic stem cells they mimic.

But a new analysis of more than 2,000 scientific papers by U-M sociologist Jason Owen-Smith and his colleagues finds that iPS cells are not replacing human embryonic stems cells in the laboratory. In fact, the two cell types have proven to be complementary, interdependent research tools, according to a commentary article scheduled for online publication June 9 in the journal Cell.

"The incentives to use both types of cell in comparative studies are high because the science behind iPS cells is still in its infancy," Owen-Smith said. "As a result, induced pluripotent stem cells do not offer an easy solution to the difficult ethical questions surrounding embryonic stem cell research."

Because use of the two cell types has become so intertwined, any federal policy that would deny funding for embryonic stem cell research "would derail work with a nascent and exciting technology," said Owen-Smith, who worked with colleagues at Stanford University and the Mayo Clinic.

In August 2010, a Washington, D.C.-based district judge, Royce Lamberth, ruled that federal funding for embryonic stem cell research is illegal because it violates a law that bans public spending on research in which human embryos are damaged or destroyed. Human embryonic stem cells are derived from days-old donated embryos left over from fertility treatments; the embryos are destroyed in the process.

On April 29, a federal appeals court blocked Lamberth's decision and ruled that federal financing of human embryonic stem cell research can continue, for now.

"We now have new data pointing to 'collateral damage' that could be caused by ill-conceived and politically motivated policy prescriptions," the authors of the Cell paper conclude. "According to the data presented here, an entirely new technology, forged out of the crucible of political controversy, is at risk."

Owen-Smith and his colleagues examined stem cell research papers published between 1998 and 2010. They found that the proportion of papers using iPS cells and human embryonic stem cells together is growing faster than those using iPS cells alone.

In 2008, only 5.1 percent (15) of all papers analyzed used induced pluripotent cell lines, and only three of those papers combined the use of iPS cells with human embryonic stem cells. By 2010, 28 percent (161 of 574) of the papers involved the use of iPS cell technologies, and 62.1 percent of those papers paired induced and embryonic cell lines.

Embryonic stem cells and iPS cells both display pluripotency, the ability to produce all the cell types in the adult body. In interviews conducted as part of the study, researchers said they often compared their iPS cells to human embryonic stem cells to verify that the iPS cells display all the characteristics of pluripotency.

"If federal funding stops for human embryonic stem cell research, it would have a serious negative impact on iPS cell research," said Stanford University bioethicist Christopher Scott, one of the co-authors. "We may never be able to choose between iPS and ES cell research because we don't know which type of cell will be best for eventual therapies."

U-M researchers work with adult stem cells, human embryonic stem cells and iPS cells. In addition to Owen-Smith and Scott, the paper's authors are Mindy DeRouen of Stanford University and Jennifer McCormick of the Mayo Clinic. The work was funded by grants from the National Science Foundation, the National Institutes of Health, and the Stanford Institute for Stem Cell Biology and Regenerative Medicine.

.


Related Links
University of Michigan
The Clone Age - Cloning, Stem Cells, Space Medicine






Comment on this article via your Facebook, Yahoo, AOL, Hotmail login.

Share this article via these popular social media networks
del.icio.usdel.icio.us DiggDigg RedditReddit GoogleGoogle








CLONE AGE
Winding back the clock with kidney stem cells
Monash, Melbourne (SPX) May 20, 2011
Stem cell research courts both controversy and support in the community- depending on your viewpoint. Now, for the first time, scientists at Monash University's Immunology and Stem Cell Laboratories (MISCL) have shown that they can make human stem cells from healthy adult kidneys without working on human embryos, circumventing ethical concerns around this research. This achievement will al ... read more


CLONE AGE
Blood Red Moon Predicted

NASA Releases New Lunar Eclipse Video

The Power of A Moon Rock

Looking at the volatile side of the Moon

CLONE AGE
Entry, descent and surface science for 2016 Mars mission

Up, Up and Away for Mars

Opportunity Heads Toward 'Spirit Point'

NASA Inspector General Report into the Management of MSL Project

CLONE AGE
Testing Spacesuits in Antarctica - part 4

Students Build Space Habitats at NASA's Johnson Space Center

Solar system edge 'bunches' in magnetic bubbles: NASA

NASA Spending Shift to Benefit Centers Focused on Science and Technology

CLONE AGE
China's second moon orbiter Chang'e-2 goes to outer space

Building harmonious outer space to achieve inclusive development

China's Fengyun-3B satellite goes into official operation

Venezuela, China to launch satellite next year

CLONE AGE
Japan astronaut tweets about space sickness

Space station puts out welcome mat

New Crew Members Arrive at ISS

Soyuz docks at ISS carrying Russian, US, Japanese astronauts

CLONE AGE
SpaceX Secures Launch Contract In Major Asian Market

SES-3 Satellite Arrives At Baikonour Launch Base

Shipments Of Sea Launch Zenit-3Sl Hardware Resume On Schedule

US Army supports student launch program

CLONE AGE
Rage Against the Dying of the Light

Second Rocky World Makes Kepler-10 a Multi-Planet System

Kepler's Astounding Haul of Multiple-Planet Systems Just Keeps Growing

Bennett team discovers new class of extrasolar planets

CLONE AGE
US computer pioneer IBM turns 100

Malaysia seals pharmaceutical company over radiation

Three in China convicted for iPad design theft

Nokia says Apple to pay royalties, ending patent disputes




The content herein, unless otherwise known to be public domain, are Copyright 1995-2014 - Space Media Network. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA Portal Reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. Advertising does not imply endorsement,agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. Privacy Statement